NCT06955052 The Effects Of "Minds In Motion The Maze" on Balance and Gate In Children With Down Syndrome
| NCT ID | NCT06955052 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Down Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-04-17 |
| Primary Completion | 2025-06-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-04-17 with a primary completion date of 2025-06-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study explores the impact of "Minds In Motion: The Maze" on balance and gait in children with Down syndrome-a population often facing motor and coordination challenges. A randomized controlled trial will be conducted with 20 participants selected through non-probability convenience sampling and randomly assigned to experimental and control groups. The intervention group will engage in the "Minds In Motion: The Maze" program, designed to enhance motor skills through interactive activities. Balance and gait will be assessed using the Berg Balance Scale, Limits of Stability Test, GOAL Test, and Timed Up and Go test at baseline and post-intervention. Data will be analyzed using SPSS version 25.0, applying parametric or non-parametric tests based on distribution. Qualitative feedback from participants, parents, and instructors will also be gathered to assess the program's broader impact. This research aims to inform therapeutic strategies to improve motor function and independence in children with Down syndrome.
Eligibility Criteria
Inclusion Criteria: * Age group from 8 to 12 years * Both male and female * Children must have the physical and cognitive ability to engage in the activities * Children should be in generally good health, without severe medical conditions or orthopedic issues * Family consents Exclusion Criteria: * Uncontrolled seizures * Any kind of orthopedic condition * Registered visually impaired * Atlanto Axial instability * Any chest infection
Contact & Investigator
Wajeeha Saeed, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06955052 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Down Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06955052 currently recruiting?
Yes, NCT06955052 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06955052 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06955052 clinical trial?
NCT06955052 is sponsored by Riphah International University. The principal investigator is Wajeeha Saeed, MS-PPT at Riphah International University. The trial plans to enroll 20 participants.